Dominique Trösch is a trained chemist having done scientific research in metal organic chemistry financed by the DAAD and the British Council. He is active in IP since 2000 and took part in multiple patent invalidation proceedings in front of the European Patent Office (e.g. EP1175904/alendronate; T 493/09 of 27 February 2013, T284/11 of 11 February 2014, ... ) and German Courts (e.g. lead sentence decision repaglinide - BGH XZR 128/09 of 11 November 2014; BPatG 3 Ni 36/04 of 27 June 2006 - SPC/alendronate; BPatG 3 Ni 37/07 of 11 November 2008 - cetirizine). Recently, he was involved with referral G 2/21 to the EPO's Enlarged Board of Appeal (G 2/21 of 23 March 2023 - reliance on a purported technical effect for inventive step (plausibility)) - often in cases also relating litigation. Besides pharmaceuticals and agrochemicals, he also has experience with other technical fields (material sciences, steel, physical chemistry, food chemistry). Experience from the aforementioned cases proves helpful drafting opinions or for conducting due diligence work.
He fluently speaks, reads and listens to German, English and French- using German and English in written procedures.
Since recently, he is also a representative in front of the UPC.
Dr. rer. nat. (Julius-Maximilians-Universität Würzburg)
President of European Patent Expert’s Exchange (EuPEX) e.V. – a registered association under German Law meeting monthly to discuss recent EPO Offical Journals and Technical Boards of Appeal Case Law;
occassionally partaking in AIPPI questionnaires;
member of the following groups, associations and chambers: PAK, EPI, FICPI, AIPPI, EuPEX, LES Germany, GRUR, GDCh (German Chemists Association) – Fachgruppe gewerblicher Rechtsschutz), BDPA.
In the UK, trade marks and the food and drink industry have a long and rich heritage. One of the most well known of these stories begins in 1876, when …Read article
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
In February 2022 two questions were referred to the Enlarged Board of Appeal of the EPO (EBoA) regarding entitlement to priority. The first question asks whether the EPO has jurisdiction …Read article
HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …Event details
The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …Read article
Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that communications are deemed to …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.